Virology Research Clinic - University of Washington
Coronavirus (COVID-19) Vaccines | CardioSmart – American College of Cardiology
COVID-19 Booster Vaccine Study | Suburban Hospital | Johns Hopkins Medicine
Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trial -
Antibody persistence and immune memory response following primary vaccination and boosting with live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) in Bangladesh: A phase 4 open-label clinical trial - ScienceDirect
Bivalent Omicron BA.1–Adapted BNT162b2 Booster in Adults Older than 55 Years | NEJM
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age | NEJM
UK volunteers to receive Moderna Omicron COVID-19 booster vaccine in clinical study | NIHR
Department of Health and Social Care on Twitter: "Everyone aged 16 and over is eligible for the #COVID19 booster from three months after their second dose. Book an appointment online or find
Virology Research Clinic - University of Washington
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial - The Lancet
Coronavirus information
COVID-19 Boosters: Why You Should Schedule One Now
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial - The Lancet
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial | Nature Medicine
Monitoring Visits in Clinical Trials
COVID vaccinations: questions and answers about the rollout in North Yorkshire - NHS North Yorkshire CCG
Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial | Signal Transduction and Targeted Therapy
Adopting a New Agile Approach to CRO Clinical Trial Management - Clinical Trial Services, UK | PHARMExcel
Looking beyond COVID-19 vaccine phase 3 trials | Nature Medicine
PRACT: a pragmatic randomized adaptive clinical trial protocol to investigate a culturally adapted brief negotiational intervention for alcohol use in the emergency department in Tanzania | Trials | Full Text
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and ...
NIH clinical trial evaluating mixed COVID-19 vaccine schedules begins | National Institutes of Health (NIH)
Getting a Flu Vaccine and a COVID-19 Vaccine at the Same Time | CDC
Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel
UC Davis and Pfizer partner on two new COVID-19 booster vaccine clinical trials
